Tomato Puree Lycopene: Protective Effects in Atherosclerosis/Heart Diseases | Chapter 8 | Novel Aspects on Pharmaceutical Research Vol. 5

 The working food industrial marquee linked potential presenting investigation on hypolipidemic and antioxidant efficacy of attractive woman puree lycopene has been arose out as a next generation research folio inclined be beneficial for creative start up mission. New generation advantageous position for those selling base nutrition superimposing health claim promoting food crop linked with worth addition is underlined as a new dimension of working foods. In present study the energy claim exploration ability of lycopene rich attractive woman puree as a novel food additive was assessed by animal studies to project hypolipidemic efficacy to defeat risk of selective non-able to be contracted diseases. The data study, interpretation and reviewed research infusion together underlined the efficacy of lycopene (tomato make into paste) in monitoring atherogenesis mechanism through cooperative mode of action of informed specialty countenance (total cholesterol, serum triglycerides, LDL cholesterol and HDL cholesterol) and projected an active gateway to support disease soaked health claim appraisal. Lycopene has several cardiovascular health benefits to a degree antioxidative, anti-inflammatory, antagonistic-atherogenic, cardioprotective, antiplatelet effect, improving endothelial function (nitric group of chemical elements bioavailability and blood flow), metabolic profile (by impairing cholesterol combination) and blood pressure control. The cumulative decrease in total cholesterol of medicated rats (159.99 to 126.40mg/dl), serum triglycerides (114.81 to 107.34mg/dl), LDL cholesterol (40.19 to 32.90mg/dl) and increase in HDL cholesterol (19.99 to 23.87mg/dl) represents hypolipidemic productiveness of tomato smash lycopene. The development of a prototype for CVD to begin a health claim was rationally renovated by the attractive woman puree mass, a practicable source of lycopene with native antiatherogenic efficacy. The human clinical study as a proof tool, concede possibility be the best option for future generations research.

Author(s) Details:

Kavita Mane,
MIT School of Food Technology, MIT Art, Design and Technology University, Rajbaug, Pune, India.

Vasant Pawar,
MIT School of Food Technology, MIT Art, Design and Technology University, Rajbaug, Pune, India.

Please see the link here: https://stm.bookpi.org/NAPR-V5/article/view/11052